Collegium Pharmaceutical Statistics
Total Valuation
COLL has a market cap or net worth of $1.18 billion. The enterprise value is $1.73 billion.
| Market Cap | 1.18B |
| Enterprise Value | 1.73B |
Important Dates
The last earnings date was Thursday, February 26, 2026, before market open.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COLL has 31.75 million shares outstanding. The number of shares has decreased by -1.79% in one year.
| Current Share Class | 31.75M |
| Shares Outstanding | 31.75M |
| Shares Change (YoY) | -1.79% |
| Shares Change (QoQ) | +1.61% |
| Owned by Insiders (%) | 1.62% |
| Owned by Institutions (%) | 112.71% |
| Float | 29.61M |
Valuation Ratios
The trailing PE ratio is 21.48 and the forward PE ratio is 5.00.
| PE Ratio | 21.48 |
| Forward PE | 5.00 |
| PS Ratio | 1.52 |
| Forward PS | 1.45 |
| PB Ratio | 3.92 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.61 |
| P/OCF Ratio | 3.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.14, with an EV/FCF ratio of 5.29.
| EV / Earnings | 27.58 |
| EV / Sales | 2.22 |
| EV / EBITDA | 4.14 |
| EV / EBIT | 8.98 |
| EV / FCF | 5.29 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 3.10.
| Current Ratio | 1.57 |
| Quick Ratio | 1.36 |
| Debt / Equity | 3.10 |
| Debt / EBITDA | 2.20 |
| Debt / FCF | 2.86 |
| Interest Coverage | 2.35 |
Financial Efficiency
Return on equity (ROE) is 23.70% and return on invested capital (ROIC) is 14.76%.
| Return on Equity (ROE) | 23.70% |
| Return on Assets (ROA) | 7.27% |
| Return on Invested Capital (ROIC) | 14.76% |
| Return on Capital Employed (ROCE) | 15.87% |
| Weighted Average Cost of Capital (WACC) | 7.08% |
| Revenue Per Employee | $1.85M |
| Profits Per Employee | $148,629 |
| Employee Count | 423 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, COLL has paid $29.75 million in taxes.
| Income Tax | 29.75M |
| Effective Tax Rate | 32.12% |
Stock Price Statistics
The stock price has increased by +27.62% in the last 52 weeks. The beta is 0.68, so COLL's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +27.62% |
| 50-Day Moving Average | 45.46 |
| 200-Day Moving Average | 38.66 |
| Relative Strength Index (RSI) | 20.85 |
| Average Volume (20 Days) | 429,678 |
Short Selling Information
The latest short interest is 4.77 million, so 15.03% of the outstanding shares have been sold short.
| Short Interest | 4.77M |
| Short Previous Month | 4.79M |
| Short % of Shares Out | 15.03% |
| Short % of Float | 16.12% |
| Short Ratio (days to cover) | 11.69 |
Income Statement
In the last 12 months, COLL had revenue of $780.57 million and earned $62.87 million in profits. Earnings per share was $1.73.
| Revenue | 780.57M |
| Gross Profit | 690.58M |
| Operating Income | 193.09M |
| Pretax Income | 92.62M |
| Net Income | 62.87M |
| EBITDA | 419.16M |
| EBIT | 193.09M |
| Earnings Per Share (EPS) | $1.73 |
Balance Sheet
The company has $386.68 million in cash and $936.43 million in debt, with a net cash position of -$549.75 million or -$17.31 per share.
| Cash & Cash Equivalents | 386.68M |
| Total Debt | 936.43M |
| Net Cash | -549.75M |
| Net Cash Per Share | -$17.31 |
| Equity (Book Value) | 301.68M |
| Book Value Per Share | 9.51 |
| Working Capital | 251.38M |
Cash Flow
In the last 12 months, operating cash flow was $329.32 million and capital expenditures -$1.74 million, giving a free cash flow of $327.58 million.
| Operating Cash Flow | 329.32M |
| Capital Expenditures | -1.74M |
| Free Cash Flow | 327.58M |
| FCF Per Share | $10.32 |
Margins
Gross margin is 88.47%, with operating and profit margins of 24.74% and 8.05%.
| Gross Margin | 88.47% |
| Operating Margin | 24.74% |
| Pretax Margin | 11.87% |
| Profit Margin | 8.05% |
| EBITDA Margin | 53.70% |
| EBIT Margin | 24.74% |
| FCF Margin | 41.97% |
Dividends & Yields
COLL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.79% |
| Shareholder Yield | 1.79% |
| Earnings Yield | 5.31% |
| FCF Yield | 27.67% |
Analyst Forecast
The average price target for COLL is $50.83, which is 36.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $50.83 |
| Price Target Difference | 36.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 1.70% |
| EPS Growth Forecast (5Y) | 30.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
COLL has an Altman Z-Score of 1.43 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.43 |
| Piotroski F-Score | 8 |